In the light of the pandemic, several measures have continuously been put in place as regards the outbreak. Most importantly, trying out the invention of vaccines capable of curing the virus.
Amongst many others is this newly launched scheme which is intended to boost domestic manufacturing of critical drugs and vaccines to ensure their sustainable domestic supply and reduce the bulk manufacturing costs of the drugs, herbal medicines and vaccines in Nigeria
Even though most universities are on strike presently, yet if our professors can come together, pull heads and resources together, it could result in the solution we have long been waiting for.
Recently, Dogonyaro – a herb in Southeast Nigeria was shipped from Nigeria to treat people in the U.S., and they recovered.
The pandemic outbreak has posed a major challenge for Africa with every country at the risk of spread of this virus. Healthcare workers are the frontliners without adequate protection made available for them.
The African Academy of Sciences (AAS) is keen to play a central role in building African Research and Development (R&D) capacity to fight COVID-19 by managing the day-to-day running of the proposed fund for COVID-19 R&D priorities in Africa. A recent survey of African scientists conducted by the AAS developed initially from an AAS ‘’All Hands’’ webinar on COVID-19 held on 26th March 2020 and conducted from the 4th to 8th of April 2020 established a priority list of Research and Development questions for the COVID-19 outbreak in Africa.
We love this new development and hope that it yields the result for which it was established.